An asymmetric split-costimulatory MSLN.BBz/NKG2D.28 dual CAR-T design enhances activity against antigenically heterogeneous pancreatic cancer
Molecular Therapy: Oncology
· Elsevier
Аннотация
Publication date: 17 December 2026 Source: Molecular Therapy Oncology, Volume 34, Issue 4 Author(s): Muhammad Auwal Saliu, Mansur Dabai Salisu, Rabiatu Bako Suleiman, Wei Liang, Abdulrahman Ibrahim, Abubakar Dalhatu, Adeleye O. Adeshakin, Isaac Adeyemi Babarinde, Guizhong Zhang, Dehong Yan, Xudong Liu, Maoxuan Liu, Xiaochun Wan
Читать у издателя →
Цитирование
An asymmetric split-costimulatory MSLN.BBz/NKG2D.28 dual CAR-T design enhances activity against antigenically heterogeneous pancreatic cancer. // Molecular Therapy: Oncology. – URL: https://www.sciencedirect.com/science/article/pii/S2950329926002250?dgcid=rss_sd_all
An asymmetric split-costimulatory MSLN.BBz/NKG2D.28 dual CAR-T design enhances activity against antigenically heterogeneous pancreatic cancer. Molecular Therapy: Oncology. https://www.sciencedirect.com/science/article/pii/S2950329926002250?dgcid=rss_sd_all
“An asymmetric split-costimulatory MSLN.BBz/NKG2D.28 dual CAR-T design enhances activity against antigenically heterogeneous pancreatic cancer.” Molecular Therapy: Oncology.
@article{article59098,
title = {An asymmetric split-costimulatory MSLN.BBz/NKG2D.28 dual CAR-T design enhances activity against antigenically heterogeneous pancreatic cancer},
journal = {Molecular Therapy: Oncology},
url = {https://www.sciencedirect.com/science/article/pii/S2950329926002250?dgcid=rss_sd_all}
}